Кеймбридж
[ ]
CM4620
Международное непатентованное наименование CM4620
Торговое наименование -
Производитель, страна CalciMedica, USA
Лекарственная форма injectable emulsion
Механизм действия

CM4620 is a calcium release-activated channel (CRAC) inhibitor which ultimately inhibits the proliferation of immune cells and prevents the release of various inflammatory cytokines. This may lead to a reduction of inflammatory responses in inflammatory-mediated diseases, such as those observed in severe cases of COVID-19.

Клинические исследования
1.
Название протокола A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion in Patients With Severe COVID-19 Pneumonia
Дата начала и окончания КИ April 8, 2020 - September 2020
Название организации, проводящей КИ CalciMedica, Inc.
Страны USA
Фаза II
Кол-во пациентов 120